|
| |
|
|
|
| |
| Clients |
- Biopharmaceutical companies dedicated to the development of biopharmaceuticals which do not have their own production capacity and need to subcontract the production of high quality protein for subsequent use in preclinical and clinical stages (I, II and III) or even the commercial phase.
- Biotech companies dedicated to the development of diagnostics that need to outsource the production of antigens, antibodies or other biological substances for design kits, arrays and other products.
- Multinationals requiring additional and flexible processing capability with a quality system comparable to their own “Quality Standards.”
- Research Centers that need quantities and qualities of product greater than their normal capabilities.
- International companies from countries outside the
EU that require official approval for their products from the European Medicines Evaluation Agency (EMEA)
in Europe and the FDA in the USA. |
| |
|
|
| |
Our relationship with our customers is based upon trust and collaboration. Our aim is to work in close cooperation with small and medium sized biotechnological and pharmaceutical companies that lack productive capacity and need to outsource for other reasons. We offer a “Comprehensive Service” which means close support to the clients during the drug development process, from the preclinical to the clinical phase, and as far as commercialisation. In addition to our own capabilities we have at our disposal those of our technological partners, which guarantee a complete service throughout the value chain of potential drug development.
|
| |
|
|
|
| |
| |
| |
|
|
|
|
